Ensayos clínicos

8.676 ensayos encontrados

ReclutandoClinicalTrials.gov

Multi-Country, Cross-sectional Study to Characterize Real World Burden of Disease in Adolescent and Adult Patients With Alopecia Areata, Vitiligo or Hidradenitis Suppurativa (MEASURE AAVitHS)

OBSERVATIONALInicio: 2 de sept de 2025ID: NCT07136467

CompletadoFase 3ClinicalTrials.gov

A Phase 3, Open-label, Randomized, Multi-center, Controlled Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of Edoxaban and to Compare the Efficacy and Safety of Edoxaban With Standard of Care Anticoagulant Therapy in Pediatric Subjects From Birth to Less Than 18 Years of Age With Confirmed Venous Thromboembolism (VTE)

INTERVENTIONALInicio: 27 de mar de 2017ID: NCT02798471

CompletadoClinicalTrials.gov

Study of Benznidazole Transfer Into Breastmilk in Lactating Women Treated for Chagas Disease

OBSERVATIONALInicio: 1 de ago de 2011ID: NCT01547533

CompletadoClinicalTrials.gov

Short and Long-term Outcomes After Transplantation With Hyper-reduced Liver Grafts in Low-Weight Pediatric Recipients

OBSERVATIONALInicio: 21 de abr de 2018ID: NCT03594864

Aún no reclutaFase 2ClinicalTrials.gov

Adrenaline in Early Sepsis Resuscitation in Children- A Randomised Controlled Pilot Study in the Emergency Department (ANDES CHILD)

INTERVENTIONALInicio: 1 de jul de 2024ID: NCT06478797

CompletadoFase 3ClinicalTrials.gov

Phase III Randomized Trial of the Safety and Efficacy of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV-1 Transmission

INTERVENTIONALInicio: 1 de feb de 2004ID: NCT00099359

CompletadoClinicalTrials.gov

Randomized, Controlled, Double Blinded, Clinical Trial: 0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Critically Ill Children

INTERVENTIONALInicio: 1 de feb de 2011ID: NCT01301274

CompletadoFase 2ClinicalTrials.gov

A Randomized, Controlled, Open-label, Multicenter, Phase IIb Safety and Efficacy Study of rhHNS (Recombinant Human Heparan N Sulfatase) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Early Stage Mucopolysaccharidosis Type IIIA Disease

INTERVENTIONALInicio: 26 de feb de 2014ID: NCT02060526

RetiradoFase 2ClinicalTrials.gov

Phase I/II, Open-Label, Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of NV1205 in Pediatric Male Subjects With Childhood Cerebral Adrenoleukodystrophy (CCALD)

INTERVENTIONALInicio: 1 de ago de 2018ID: NCT03196765

CompletadoFase 3ClinicalTrials.gov

IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome

INTERVENTIONALID: NCT00368173

CompletadoFase 3ClinicalTrials.gov

A 26 Week, Randomized, Double-blind, Parallel-group, Active Controlled, Multicenter, Multinational Safety Study Evaluating the Risk of Serious Asthma-related Events During Treatment With Symbicort®, a Fixed Combination of Inhaled Corticosteroid (ICS) (Budesonide) and a Long Acting β2-agonist (LABA) (Formoterol) as Compared to Treatment With ICS (Budesonide) Alone in Adult and Adolescent (≥12 Years of Age) Patients With Asthma

INTERVENTIONALInicio: 1 de dic de 2011ID: NCT01444430

ReclutandoFase 3ClinicalTrials.gov

A Phase 2/3, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1

INTERVENTIONALInicio: 20 de nov de 2024ID: NCT06532656

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Orally Administered Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema

INTERVENTIONALInicio: 1 de dic de 2024ID: NCT06669754

TerminadoFase 4ClinicalTrials.gov

AN OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE PHARMACOKINETICS OF SINGLE AND MULTIPLE INTRAVENOUS DOSES OF PANTOPRAZOLE IN TWO AGE COHORTS OF HOSPITALIZED PEDIATRIC SUBJECTS 1 TO 16 YEARS OF AGE WHO ARE CANDIDATES FOR ACID SUPPRESSION THERAPY

INTERVENTIONALInicio: 9 de may de 2017ID: NCT02401035

CompletadoClinicalTrials.gov

Pediatric Virtual Visits as a Strategy for Access to Care During the COVID-19 Pandemic in a Pediatric Hospital. Missed Appointments Rates, Associated Factors, Generation and Validation of Predictive Models

OBSERVATIONALInicio: 1 de mar de 2021ID: NCT04736680

CompletadoFase 2ClinicalTrials.gov

A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY OF THE EFFICACY, SAFETY AND TOLERABILITY OF RG1662 IN ADULTS AND ADOLESCENTS WITH DOWN SYNDROME (CLEMATIS)

INTERVENTIONALInicio: 5 de may de 2014ID: NCT02024789

CompletadoFase 3ClinicalTrials.gov

An Open-label Single-arm Multicentre Non-controlled Phase 3a Trial Investigating Safety and Efficacy of N8-GP in Prophylaxis and Treatment of Bleeding Episodes in Previously Untreated Paediatric Patients With Severe Haemophilia A

INTERVENTIONALInicio: 26 de jun de 2014ID: NCT02137850

CompletadoFase 3ClinicalTrials.gov

A Multi-center, Phase III, Non-controlled, Open-label Trial to Evaluate the Pharmacokinetics, Safety, and Efficacy of BAY94-9027 for Prophylaxis and Treatment of Bleeding in Previously Treated Children (Age <12 Years) With Severe Hemophilia A

INTERVENTIONALInicio: 29 de may de 2013ID: NCT01775618

ReclutandoFase 3ClinicalTrials.gov

Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Eptinezumab in Paediatric Patients (6 to 17 Years) for the Preventive Treatment of Episodic Migraine

INTERVENTIONALInicio: 8 de jun de 2023ID: NCT05897320

CompletadoFase 3ClinicalTrials.gov

A Two-arm, Phase 2/3 Multicentre, Open-label, Randomised Study Evaluating Safety and Antiviral Effect of Current Standard Antiretroviral Therapy Compared to Once Daily Integrase Inhibitor Administered With Darunavir/Ritonavir (DRV/r) in HIV-1 Infected, Virologically Suppressed Paediatric Participants.

INTERVENTIONALInicio: 1 de jun de 2016ID: NCT02383108